45 related articles for article (PubMed ID: 29080451)
1. Curcumin sensitizes lymphoma cells to DNA damage agents through regulating Rad51-dependent homologous recombination.
Zhao Q; Guan J; Qin Y; Ren P; Zhang Z; Lv J; Sun S; Zhang C; Mao W
Biomed Pharmacother; 2018 Jan; 97():115-119. PubMed ID: 29080451
[TBL] [Abstract][Full Text] [Related]
2. IGF-I protects porcine granulosa cells from hypoxia-induced apoptosis by promoting homologous recombination repair through the PI3K/AKT/E2F8/RAD51 pathway.
Liu Z; Feng C; Li C; He T; Wu G; Fu C; Li H; Shen M; Liu H
FASEB J; 2024 Jan; 38(1):e23332. PubMed ID: 38095232
[TBL] [Abstract][Full Text] [Related]
3. In vivo reduction of RAD51-mediated homologous recombination triggers aging but impairs oncogenesis.
Matos-Rodrigues G; Barroca V; Muhammad AA; Dardillac E; Allouch A; Koundrioukoff S; Lewandowski D; Despras E; Guirouilh-Barbat J; Frappart L; Kannouche P; Dupaigne P; Le Cam E; Perfettini JL; Romeo PH; Debatisse M; Jasin M; Livera G; Martini E; Lopez BS
EMBO J; 2023 Oct; 42(20):e110844. PubMed ID: 37661798
[TBL] [Abstract][Full Text] [Related]
4. Isolation and Characterization of Monomeric Human RAD51: A Novel Tool for Investigating Homologous Recombination in Cancer.
Rinaldi F; Schipani F; Balboni B; Catalano F; Marotta R; Myers SH; Previtali V; Veronesi M; Scietti L; Cecatiello V; Pasqualato S; Ortega JA; Girotto S; Cavalli A
Angew Chem Int Ed Engl; 2023 Dec; 62(51):e202312517. PubMed ID: 37924230
[TBL] [Abstract][Full Text] [Related]
5. Homologous recombination contributes to the repair of acetaldehyde-induced DNA damage.
Yamazaki K; Iguchi T; Kanoh Y; Takayasu K; Ngo TTT; Onuki A; Kawaji H; Oshima S; Kanda T; Masai H; Sasanuma H
Cell Cycle; 2024 Feb; 23(4):369-384. PubMed ID: 38571319
[TBL] [Abstract][Full Text] [Related]
6. The recombinase Rad51 plays a key role in events of genetic exchange in Trypanosoma cruzi.
Alves CL; Repolês BM; da Silva MS; Mendes IC; Marin PA; Aguiar PHN; Santos SDS; Franco GR; Macedo AM; Pena SDJ; Andrade LO; Guarneri AA; Tahara EB; Elias MC; Machado CR
Sci Rep; 2018 Sep; 8(1):13335. PubMed ID: 30190603
[TBL] [Abstract][Full Text] [Related]
7. BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombination.
Parker C; Chambers AC; Flanagan DJ; Ho JWY; Collard TJ; Ngo G; Baird DM; Timms P; Morgan RG; Sansom OJ; Williams AC
DNA Repair (Amst); 2022 Jul; 115():103331. PubMed ID: 35468497
[TBL] [Abstract][Full Text] [Related]
8. RAD51 Inhibitor and Radiation Toxicity in Vestibular Schwannoma.
Thielhelm TP; Nourbakhsh A; Welford SM; Mellon EA; Bracho O; Ivan ME; Telischi F; Fernandez-Valle C; Dinh CT
Otolaryngol Head Neck Surg; 2022 Nov; 167(5):860-868. PubMed ID: 35230908
[TBL] [Abstract][Full Text] [Related]
9. Niraparib in ovarian cancer: results to date and clinical potential.
Caruso D; Papa A; Tomao S; Vici P; Panici PB; Tomao F
Ther Adv Med Oncol; 2017 Sep; 9(9):579-588. PubMed ID: 29081841
[TBL] [Abstract][Full Text] [Related]
10. PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP Inhibitors.
Parsels LA; Karnak D; Parsels JD; Zhang Q; Vélez-Padilla J; Reichert ZR; Wahl DR; Maybaum J; O'Connor MJ; Lawrence TS; Morgan MA
Mol Cancer Res; 2018 Feb; 16(2):222-232. PubMed ID: 29133592
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic targeting of PGBD5-induced DNA repair dependency in pediatric solid tumors.
Henssen AG; Reed C; Jiang E; Garcia HD; von Stebut J; MacArthur IC; Hundsdoerfer P; Kim JH; de Stanchina E; Kuwahara Y; Hosoi H; Ganem NJ; Dela Cruz F; Kung AL; Schulte JH; Petrini JH; Kentsis A
Sci Transl Med; 2017 Nov; 9(414):. PubMed ID: 29093183
[TBL] [Abstract][Full Text] [Related]
12. Curcumin and endometriosis: Review on potential roles and molecular mechanisms.
Arablou T; Kolahdouz-Mohammadi R
Biomed Pharmacother; 2018 Jan; 97():91-97. PubMed ID: 29080464
[TBL] [Abstract][Full Text] [Related]
13. Combined PARP and ATR inhibition potentiates genome instability and cell death in ATM-deficient cancer cells.
Lloyd RL; Wijnhoven PWG; Ramos-Montoya A; Wilson Z; Illuzzi G; Falenta K; Jones GN; James N; Chabbert CD; Stott J; Dean E; Lau A; Young LA
Oncogene; 2020 Jun; 39(25):4869-4883. PubMed ID: 32444694
[TBL] [Abstract][Full Text] [Related]
14. Natural products reverse cancer multidrug resistance.
Zou JY; Chen QL; Luo XC; Damdinjav D; Abdelmohsen UR; Li HY; Battulga T; Chen HB; Wang YQ; Zhang JY
Front Pharmacol; 2024; 15():1348076. PubMed ID: 38572428
[TBL] [Abstract][Full Text] [Related]
15. Curcumin in treatment of hematological cancers: Promises and challenges.
Entezari M; Tayari A; Paskeh MDA; Kheirabad SK; Naeemi S; Taheriazam A; Dehghani H; Salimimoghadam S; Hashemi M; Mirzaei S; Samarghandian S
J Tradit Complement Med; 2024 Mar; 14(2):121-134. PubMed ID: 38481552
[TBL] [Abstract][Full Text] [Related]
16. Qin Huang formula enhances the effect of Adriamycin in B-cell lymphoma via increasing tumor infiltrating lymphocytes by targeting toll-like receptor signaling pathway.
Li W; Lv L; Ruan M; Xu J; Zhu W; Li Q; Jiang X; Zheng L; Zhu W
BMC Complement Med Ther; 2022 Jul; 22(1):185. PubMed ID: 35818037
[TBL] [Abstract][Full Text] [Related]
17. Targeting HR Repair as a Synthetic Lethal Approach to Increase DNA Damage Sensitivity by a RAD52 Inhibitor in BRCA2-Deficient Cancer Cells.
Tseng WC; Chen CY; Chern CY; Wang CA; Lee WC; Chi YC; Cheng SF; Kuo YT; Chiu YC; Tseng ST; Lin PY; Liou SJ; Li YC; Chen CC
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922657
[TBL] [Abstract][Full Text] [Related]
18. Natural Compounds That Target DNA Repair Pathways and Their Therapeutic Potential to Counteract Cancer Cells.
Lagunas-Rangel FA; Bermúdez-Cruz RM
Front Oncol; 2020; 10():598174. PubMed ID: 33330091
[TBL] [Abstract][Full Text] [Related]
19. Molecular Insights into the Multifunctional Role of Natural Compounds: Autophagy Modulation and Cancer Prevention.
Rahman MA; Rahman MDH; Hossain MS; Biswas P; Islam R; Uddin MJ; Rahman MH; Rhim H
Biomedicines; 2020 Nov; 8(11):. PubMed ID: 33228222
[TBL] [Abstract][Full Text] [Related]
20. [Bortezomib interferes with DNA repair and exerts synergistic anti-multiple myeloma activity with doxorubicin].
Tang HL; Xu L; Chen XQ
Zhonghua Xue Ye Xue Za Zhi; 2020 May; 41(5):417-421. PubMed ID: 32536140
[No Abstract] [Full Text] [Related]
[Next] [New Search]
